Patents by Inventor Regina Lundrigan

Regina Lundrigan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8884020
    Abstract: Indole derivatives that are useful for treating pain, inflammation and other conditions are described. Certain of the compounds are benzyl derivatives and others are benzoyl derivatives. The compounds are substituted at least at the 3 position of the indole.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: November 11, 2014
    Assignee: Ironwood Pharmaceuticals, Inc.
    Inventors: John Jeffrey Talley, Kevin Sprott, James Philip Pearson, G. Todd Milne, Wayne Schairer, Jane Yang, Charles Kim, Timothy Barden, Regina Lundrigan, Ara Mermerian, Mark G. Currie
  • Publication number: 20100197708
    Abstract: Indole derivatives that are useful for treating pain, inflammation and other conditions are described. Certain of the compounds are benzyl derivatives and others are benzoyl derivatives. The compounds are substituted at least at the 3 position of the indole.
    Type: Application
    Filed: August 7, 2007
    Publication date: August 5, 2010
    Inventors: John Jeffrey Talley, Kevin Sprott, James Philip Pearson, G. Todd Milne, Wayne Schairer, Jane Yang, Charles Kim, Timothy Barden, Regina Lundrigan, Ara Mermerian, Mark G. Currie
  • Publication number: 20090186834
    Abstract: Various azetidinone, pyrrolidine, imidazolidine, and oxazolidine derivatives are described, as are pharmaceutical compositions containing these compounds and methods of treatment of diseases using these compounds. Other embodiments are also described.
    Type: Application
    Filed: March 24, 2006
    Publication date: July 23, 2009
    Applicant: MICROBIA, INC.
    Inventors: John Talley, Eduardo Martinez, Daniel Zimmer, Regina Lundrigan
  • Publication number: 20090131395
    Abstract: The invention relates to a chemical genus of 4-biphenyl-1-phenylazetidin-2-ones useful in the treatment of hypercholesterolemia and other disorders. The compounds have the general formula I: Pharmaceutical compositions and methods for treating cholesterol- and lipid-associated diseases are also disclosed.
    Type: Application
    Filed: May 5, 2006
    Publication date: May 21, 2009
    Applicant: MICROBIA, INC.
    Inventors: Stephen Antonelli, Regina Lundrigan, Eduardo J. Martinez, Wayne C. Schairer, John J. Talley, Timothy C. Barden, JingJing Yang, Daniel P. Zimmer
  • Publication number: 20090005321
    Abstract: Various azetidinone derivatives are described, as are pharmaceutical compositions containing these compounds and methods of treatment of diseases using these compounds. Other embodiments are also described.
    Type: Application
    Filed: February 9, 2006
    Publication date: January 1, 2009
    Applicant: Microbia, Inc.
    Inventors: Daniel P. Zimmer, John Jeffrey Talley, Regina Lundrigan, Shannon Roberts, Eduardo J. Martinez
  • Publication number: 20080287663
    Abstract: The present invention relates to processes for the production of 4-biphenylylazetidin-2-one derivatives of formula
    Type: Application
    Filed: May 8, 2006
    Publication date: November 20, 2008
    Applicant: MICROBIA, INC.
    Inventors: Peter Lee, Stephen Antonelli, Regina Lundrigan, Eduardo J. Martinez, Wayne C. Schairer, John J. Talley
  • Publication number: 20080194494
    Abstract: The invention relates to a chemical genus of 4-biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia and other disorders, having general formula: Pharmaceutical compositions and methods for treating cholesterol- and lipid-associated diseases are also disclosed.
    Type: Application
    Filed: April 26, 2006
    Publication date: August 14, 2008
    Applicant: MICROBIA, INC.
    Inventors: Eduardo J. Martinez, John Jeffrey Talley, Regina Lundrigan
  • Publication number: 20080167255
    Abstract: 4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formula in which represents an aryl or heteroaryl residue; Ar represents an aryl residue; U is a two to six atom chain; and the R's represent substituents.
    Type: Application
    Filed: December 11, 2007
    Publication date: July 10, 2008
    Applicant: MICROBIA, INC.
    Inventors: Eduardo J. Martinez, John J. Talley, Stephen Antonelli, Timothy C. Barden, Regina Lundrigan-Soucy, Wayne C. Schairer, Jing-Jing Yang, Daniel P. Zimmer, Brian Cali, Mark G. Currie, Peter S. Yorgey
  • Patent number: 7320972
    Abstract: 4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formula in which represents an aryl or heteroaryl residue; Ar represents an aryl residue; U is a two to six atom chain; and the R's represent substituents.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: January 22, 2008
    Assignee: Microbia, Inc.
    Inventors: Eduardo Martinez, John J. Talley, Stephen Antonelli, Timothy C. Barden, Regina Lundrigan-Soucy, Wayne C. Schairer, Jing-Jing Yang, Daniel P. Zimmer, Brian Cali, Mark G. Currie, Peter S. Yorgey
  • Publication number: 20050209165
    Abstract: 4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formula in which represents an aryl or heteroaryl residue; Ar represents an aryl residue; U is a two to six atom chain; and the R's represent substituents.
    Type: Application
    Filed: November 10, 2004
    Publication date: September 22, 2005
    Inventors: Eduardo Martinez, John Talley, Stephen Antonelli, Timothy Barden, Regina Lundrigan-Soucy, Wayne Schairer, Jing-Jing Yang, Daniel Zimmer